In February, amfAR awarded the first round of new Innovation Grants designed to spur innovation by supporting novel ideas based on limited preliminary data.
Intriguing finding has scientific community abuzz
In a novel approach to conquering HIV, amfAR, The Foundation for AIDS Research, is pairing HIV researchers with bioengineers to address the main barrier to a cure for HIV: the persistent reservoirs of virus not cleared by antiretroviral therapy. A new round of Investment grants, totaling $1.2 million, will support six new research projects aimed at bringing to bear highly advanced technologies that until recently might have belonged in the pages of a science fiction novel.
Scientists at Case Western Reserve University School of Medicine have received $2.5 million from the pharmaceutical company Gilead Sciences to test two never-before-combined HIV treatments on patients.
Gene therapy — which involves modifying genetic material, such as DNA and RNA — holds exciting potential as a cure for numerous diseases and conditions, including HIV.